{
    "clinical_study": {
        "@rank": "33271", 
        "arm_group": [
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo"
            }, 
            {
                "arm_group_label": "rosuvastatin 5", 
                "arm_group_type": "Active Comparator", 
                "description": "rosuvastatin 5 mg"
            }, 
            {
                "arm_group_label": "rosuvastatin 10", 
                "arm_group_type": "Active Comparator", 
                "description": "rosuvastatin 10 mg"
            }, 
            {
                "arm_group_label": "rosuvastatin 20", 
                "arm_group_type": "Active Comparator", 
                "description": "rosuvastatin 20 mg"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators hypothesize that rosuvastatin does-dependently worsens insulin\n      sensitivity."
        }, 
        "brief_title": "Vascular and Metabolic Effects of Rosuvastatin", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypercholesterolemia", 
        "condition_browse": {
            "mesh_term": "Hypercholesterolemia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  hypercholesterolemia\n\n        Exclusion Criteria:\n\n          -  overt liver disease, chronic renal failure, hypothyroidism, myopathy, uncontrolled\n             diabetes (HbA1c > 9%), severe hypertension, stroke, acute coronary events, coronary\n             revascularization within the preceding 3 months, or alcohol abuse"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 8, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01660919", 
            "org_study_id": "GMC-201105"
        }, 
        "intervention": [
            {
                "arm_group_label": "placebo", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "rosuvastatin 5", 
                    "rosuvastatin 10", 
                    "rosuvastatin 20"
                ], 
                "intervention_name": "rosuvastatin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Rosuvastatin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "insulin resistance", 
        "lastchanged_date": "August 8, 2012", 
        "location": {
            "contact": {
                "email": "shhan@gilhospital.com", 
                "last_name": "Seung H Han, MD", 
                "phone": "82-32-460-3650"
            }, 
            "facility": {
                "address": {
                    "city": "Incheon", 
                    "country": "Korea, Republic of", 
                    "zip": "405-760"
                }, 
                "name": "Gil Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "4", 
        "overall_contact": {
            "email": "kwangk@gilhospital.com", 
            "last_name": "Kwang K Koh, MD,PhD", 
            "phone": "82-32-460-3683"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "flow-mediated dilation", 
            "safety_issue": "No", 
            "time_frame": "8 weeks of treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01660919"
        }, 
        "secondary_outcome": {
            "measure": "insulin resistance", 
            "safety_issue": "No", 
            "time_frame": "8 weeks of treatment"
        }, 
        "source": "Gachon University Gil Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gachon University Gil Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}